HuGE Literature Finder
Records
1
-
3
Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Scientific reports 2020 Apr 10 (1): 7188. Yoneyama Seigo, Sakurada Yoichi, Kikushima Wataru, Sugiyama Atsushi, Matsubara Mio, Fukuda Yoshiko, Tanabe Naohiko, Parikh Ravi, Mabuchi Fumihiko, Kashiwagi Kenji, Iijima Hiroyu |
ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2017 Jul . Valverde-Megías Alicia, Veganzones-de-Castro Silvia, Donate-López Juan, Maestro-de-Las-Casas Maria Luisa, Megías-Fresno Alicia, García-Feijoo Juli |
Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population. Taiwan journal of ophthalmology 0 9 (4): 243-248. Rodríguez Francisco Jose, Rios Hernan Andres, Aguilar María Camila, Rosenstiehl Shirley Margarita, Gelvez Nancy, Lopez Greizy, Tamayo Martha |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: